2. Signaling Pathways
  3. Others
  4. Drug Intermediate

Drug Intermediate

Drug Iintermediate

Drug intermediates are used as raw materials for the production of bulk drugs, or they can refer to a material produced during synthesis of an API that must undergo further molecular change or processing before it becomes an API. Drug intermediates are hygienically formulated using high grade raw materials and they are used in the pharmaceutical and cosmetic industry[1][2].

Drug Intermediate Related Products (2203):

Cat. No. Product Name Effect Purity Chemical Structure
  • HY-44919
    Methyl 3-((tert-butoxycarbonyl)amino)-5-iodothiophene-2-carboxylate
    		99.68%
    Methyl 3-((tert-butoxycarbonyl)amino)-5-iodothiophene-2-carboxylate is a drug intermediate for synthesis of various active compounds.
    Methyl 3-((tert-butoxycarbonyl)amino)-5-iodothiophene-2-carboxylate
  • HY-77600
    tert-Butyl 4-(3-methyl-1-phenyl-1H-pyrazol-5-yl)piperazine-1-carboxylate
    		99.94%
    tert-Butyl 4-(3-methyl-1-phenyl-1H-pyrazol-5-yl)piperazine-1-carboxylate is a drug intermediate for synthesis of various active compounds.
    tert-Butyl 4-(3-methyl-1-phenyl-1H-pyrazol-5-yl)piperazine-1-carboxylate
  • HY-W599086
    3-((tert-Butoxycarbonyl)amino)-7-fluoro-8-((triisopropylsilyl)ethynyl)naphthalen-1-yl trifluoromethanesulfonate
    3-((tert-Butoxycarbonyl)amino)-7-fluoro-8-((triisopropylsilyl)ethynyl)naphthalen-1-yl trifluoromethanesulfonate is a drug intermediate for synthesis of various active compounds.
    3-((tert-Butoxycarbonyl)amino)-7-fluoro-8-((triisopropylsilyl)ethynyl)naphthalen-1-yl trifluoromethanesulfonate
  • HY-I0616A
    (S)-1-(3-Ethoxy-4-methoxyphenyl)-2-(methylsulfonyl)ethylamine N-acetyl-L-leucine
    		99.99%
    (S)-1-(3-Ethoxy-4-methoxyphenyl)-2-(methylsulfonyl)ethylamine N-acetyl-L-leucine is a drug intermediate for synthesis of various active compounds.
    (S)-1-(3-Ethoxy-4-methoxyphenyl)-2-(methylsulfonyl)ethylamine N-acetyl-L-leucine
  • HY-X0017
    4-(Hydroxymethyl)oxane-4-carbonitrile
    		99.91%
    4-(Hydroxymethyl)oxane-4-carbonitrile is a drug intermediate for synthesis of various active compounds.
    4-(Hydroxymethyl)oxane-4-carbonitrile
  • HY-Z4535
    Nintedanib impurity 6
    		99.90%
    Nintedanib impurity 6 is an impurity of Nintedanib (HY-50904).
    Nintedanib impurity 6
  • HY-W249042
    4,5,6,7-Tetrahydrobenzo[d]isoxazol-5-amine hydrochloride
    		99.97%
    4,5,6,7-Tetrahydrobenzo[d]isoxazol-5-amine hydrochloride is a drug intermediate for synthesis of various active compounds.
    4,5,6,7-Tetrahydrobenzo[d]isoxazol-5-amine hydrochloride
  • HY-Z0022
    Nintedanib impurity 4
    		99.73%
    Nintedanib impurity 4 is an impurity of Nintedanib (HY-50904).
    Nintedanib impurity 4
  • HY-42841
    (2S,4S)-1-(tert-Butoxycarbonyl)-4-(4-(3-methyl-1-phenyl-1H-pyrazol-5-yl)piperazin-1-yl)pyrrolidine-2-carboxylic acid
    (2S,4S)-1-(tert-Butoxycarbonyl)-4-(4-(3-methyl-1-phenyl-1H-pyrazol-5-yl)piperazin-1-yl)pyrrolidine-2-carboxylic acid is a drug intermediate for synthesis of various active compounds.
    (2S,4S)-1-(tert-Butoxycarbonyl)-4-(4-(3-methyl-1-phenyl-1H-pyrazol-5-yl)piperazin-1-yl)pyrrolidine-2-carboxylic acid
  • HY-79654
    5-Chloro-4-formyl-3-methyl-1-phenylpyrazole
    		99.93%
    5-Chloro-4-formyl-3-methyl-1-phenylpyrazole is a drug intermediate for synthesis of various active compounds.
    5-Chloro-4-formyl-3-methyl-1-phenylpyrazole
  • HY-76718
    1,3-Dimethylpiperidin-4-one
    		99.63%
    1,3-Dimethylpiperidin-4-one is a drug intermediate for synthesis of various active compounds.
    1,3-Dimethylpiperidin-4-one
  • HY-75473
    (R)-tert-Butyl 4-(4-(6-amino-5-(1-(2,6-dichloro-3-fluorophenyl)ethoxy)pyridin-3-yl)-1H-pyrazol-1-yl)piperidine-1-carboxylate
    		98.13%
    (R)-tert-Butyl 4-(4-(6-amino-5-(1-(2,6-dichloro-3-fluorophenyl)ethoxy)pyridin-3-yl)-1H-pyrazol-1-yl)piperidine-1-carboxylate is a drug intermediate for synthesis of various active compounds.
    (R)-tert-Butyl 4-(4-(6-amino-5-(1-(2,6-dichloro-3-fluorophenyl)ethoxy)pyridin-3-yl)-1H-pyrazol-1-yl)piperidine-1-carboxylate
  • HY-W027691A
    3-(Prop-2-yn-1-yloxy)aniline hydrochloride
    3-(Prop-2-yn-1-yloxy)aniline hydrochloride is a drug intermediate for synthesis of various active compounds.
    3-(Prop-2-yn-1-yloxy)aniline hydrochloride
  • HY-I0459
    Apixaban impurity 41
    Apixaban impurity 41 is an impurity of Apixaban (HY-50667).
    Apixaban impurity 41
  • HY-W008393
    (-)-Corey lactone diol
    		98.0%
    (-)-Corey lactone diol is the reduced form of Corey aldehyde. (-)-Corey lactone diol can be used as a drug intermediate for the synthesis of Beraprost (HY-13569A).
    (-)-Corey lactone diol
  • HY-W015575
    2-Chlorobenzimidazole
    		99.54%
    2-Chlorobenzimidazole is a pharmaceutical intermediate used in the synthesis of a series of derivatives with anti-human cytomegalovirus (HCMV) activity. 2-Chlorobenzimidazole can be used to form metal complexes (cobalt, copper, and zinc), with zinc complexes exhibiting significant anticancer activity.
    2-Chlorobenzimidazole
  • HY-Y0247
    6-Chloropurine
    		99.47%
    6-Chloropurine is a building block in chemical synthesis. Intermediate in the preparation of 9-alkylpurines and 6-rnercaptopurine. Antitumor activities.
    6-Chloropurine
  • HY-W012874
    D-Threonine
    		≥98.0%
    D-Threonine (H-D-Thr-OH) is one of the important unnatural amino acids used as chiral building blocks in pharmaceutical drugs. D-Threonine is a metabolite of Saccharomyces cerevisiae. D-Threonine is cleaved into glycine and acetaldehyde by the catalytic action of D-threonine aldolase.
    D-Threonine
  • HY-Y0084
    3,4,5-Trimethoxybenzoic acid
    		99.90%
    3,4,5-Trimethoxybenzoic acid (Eudesmic acid;Trimethylgallic Acid) is a benzoic acid derivative. A building block in medicine and organic synthesis. 3,4,5-Trimethoxybenzoic acid exhibits antibacterial activity against S. aureus with MIC of 0.97 μg/mL.
    3,4,5-Trimethoxybenzoic acid
  • HY-78197
    3,5-Dimethylisoxazole-4-boronic acid pinacol ester
    		99.07%
    3,5-Dimethylisoxazole-4-boronic acid pinacol ester is a drug intermediate that can be used for the synthesis of bromodomain inhibitors.
    3,5-Dimethylisoxazole-4-boronic acid pinacol ester